Alembic Pharmaceuticals Ltd

🇩🇪 Alembic Pharmaceuticals Expands into Germany with New Subsidiary

• Alembic Pharmaceuticals Limited has incorporated a wholly owned subsidiary named Alembic Pharmaceuticals GmbH in Germany.

• The subsidiary has a share capital of EUR 25,000, divided into 25,000 shares each valued at EUR 1.00.

• The purpose is to explore new business opportunities in Germany for promoting, selling, and distributing pharmaceutical products.

• The subsidiary has not yet commenced business operations, so its current turnover is nil.

• Alembic Pharmaceuticals Limited holds 100% ownership in the new subsidiary.